Fulford (India) is currently trading at Rs. 685.00, up by 43.90 points or 6.85% from its previous closing of Rs. 641.10 on the BSE.
The scrip opened at Rs. 685.00 and has touched a high and low of Rs. 685.00 and Rs. 685.00 respectively.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 957.90 on 11-Sep-2012 and a 52 week low of Rs. 601.25 on 04-Jun-2012.
Last one week high and low of the scrip stood at Rs. 685.00 and Rs. 640.00 respectively. The current market cap of the company is Rs. 267.15 crore.
The promoters holding in the company stood at 54.19% while Institutions and Non-Institutions held 6.65% and 39.16% respectively.
After raising Rs 40.25 crore by issuing 700,000 equity shares to its promoters Dashtag, Fulford India has utilized Rs 39 lakh towards business expansion during the quarter ended March 31, 2013. The total amount utilized towards business expansion till March 31, 2013, out of the aforesaid amount, is Rs 2 crore. The remaining balance amount of Rs 38.25 crore continue to be invested in fixed deposits with banks pending utilization of the same.
The company has raised the said funds to the tune of Rs 40.25 crore to provide capital in order to permit the company to strengthen its position in the market and act on strategic business growth opportunities.
Fulford (India) is engaged in the business of manufacturing and marketing pharmaceutical consumer products, including cough tablets and herbal ointments, marketed under the trademarks - PEPS and ZAMBUK respectively. It offers medicines for the treatment of allergy and respiratory, arthritis and immunology, cancer therapies, cardiovascular, hepatitis, sun care, etc.
| Company Name | CMP |
|---|---|
| Redington | 234.90 |
| Adani Enterprises | 2218.35 |
| Amrapali Industries | 17.53 |
| Rashi Peripheral | 455.25 |
| PDS | 301.45 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: